ZA92341B - Substituted 1,2,3,4-tetrahydrocyclopent(b)indoles,1,2,3,3a,4,8a-hexahydrocyclopent(b)indoles and related compounds,intermediates and a process for the preparation thereof and their use as medicaments - Google Patents

Substituted 1,2,3,4-tetrahydrocyclopent(b)indoles,1,2,3,3a,4,8a-hexahydrocyclopent(b)indoles and related compounds,intermediates and a process for the preparation thereof and their use as medicaments

Info

Publication number
ZA92341B
ZA92341B ZA92341A ZA92341A ZA92341B ZA 92341 B ZA92341 B ZA 92341B ZA 92341 A ZA92341 A ZA 92341A ZA 92341 A ZA92341 A ZA 92341A ZA 92341 B ZA92341 B ZA 92341B
Authority
ZA
South Africa
Prior art keywords
indoles
intermediates
preparation
hexahydrocyclopent
tetrahydrocyclopent
Prior art date
Application number
ZA92341A
Other languages
English (en)
Inventor
Helen Hu Ong
Hu Ong Helen
Gerard Joseph O'malley
Joseph O'malley Gerard
Michael Clayton Merriman
Clayton Merriman Michael
Mark Gabriel Palermo
Gabriel Palermo Mark
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of ZA92341B publication Critical patent/ZA92341B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA92341A 1991-01-18 1992-01-17 Substituted 1,2,3,4-tetrahydrocyclopent(b)indoles,1,2,3,3a,4,8a-hexahydrocyclopent(b)indoles and related compounds,intermediates and a process for the preparation thereof and their use as medicaments ZA92341B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/642,952 US5100891A (en) 1991-01-18 1991-01-18 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds

Publications (1)

Publication Number Publication Date
ZA92341B true ZA92341B (en) 1992-09-30

Family

ID=24578739

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92341A ZA92341B (en) 1991-01-18 1992-01-17 Substituted 1,2,3,4-tetrahydrocyclopent(b)indoles,1,2,3,3a,4,8a-hexahydrocyclopent(b)indoles and related compounds,intermediates and a process for the preparation thereof and their use as medicaments

Country Status (26)

Country Link
US (1) US5100891A (de)
EP (1) EP0496314B1 (de)
JP (1) JP2665422B2 (de)
KR (1) KR100230881B1 (de)
AT (1) ATE158790T1 (de)
AU (1) AU650315B2 (de)
BR (1) BR9200171A (de)
CA (1) CA2059610C (de)
CZ (1) CZ282732B6 (de)
DE (1) DE69222444T2 (de)
DK (1) DK0496314T3 (de)
ES (1) ES2109953T3 (de)
FI (2) FI102174B1 (de)
GR (1) GR3025318T3 (de)
HU (1) HUT67027A (de)
IE (1) IE920149A1 (de)
IL (1) IL100693A0 (de)
MX (1) MX9200206A (de)
NO (1) NO178397C (de)
NZ (1) NZ241305A (de)
PH (1) PH31429A (de)
PL (2) PL169417B1 (de)
RO (1) RO112505B1 (de)
RU (1) RU2077530C1 (de)
TW (1) TW198024B (de)
ZA (1) ZA92341B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298626A (en) * 1991-01-18 1994-03-29 Hoechst-Roussel Pharmaceuticals Incorporated Select cyclopent[b]indoles
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds
DE997458T1 (de) * 1997-07-03 2001-03-01 Asahi Kasei Kogyo K.K., Osaka Tricyclische verbindungen mit gesättigten ringen und diese enthaltende medizinische zubereitungen
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
UA70334C2 (en) * 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
SK285386B6 (sk) * 1998-10-06 2006-12-07 Janssen Pharmaceutica N. V. Tricyklické delta3-piperidíny ako farmaceutiká a spôsob ich prípravy
IT1317926B1 (it) 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Derivati triciclici dell'indolo ad attivita' antiangiogenica.
CA2528321A1 (en) 2003-06-10 2004-12-23 Smithkline Beecham Corporation Tetrahydrocarbazole derivatives and their pharmaceutical use
RU2005138126A (ru) 2003-06-12 2006-07-27 СмитКлайн Бичем Корпорейшн (US) Производные тетрагидрокарбазола и их фармацевтическое применение
US8143257B2 (en) * 2004-11-23 2012-03-27 Ptc Therapeutics, Inc. Substituted phenols as active agents inhibiting VEGF production
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue
WO2013139929A1 (en) * 2012-03-22 2013-09-26 Ludwig-Maximilians-Universität München Novel means and methods for treating diseases of the central nervous system, metabolic and cardiac diseases and aging
KR20140013471A (ko) 2012-07-24 2014-02-05 주식회사 쎄코 진공증착용 발열조립체 및 이를 구비하는 진공증착장치
US10882821B1 (en) 2017-09-26 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514462A (en) * 1966-10-21 1970-05-26 Upjohn Co 1 and 2 ethoxy 3,4,5,10 - tetrahydroazepino(3,4-b) and (2,3-b)indoles and corresponding amino derivatives thereof
US3595874A (en) * 1969-02-28 1971-07-27 Upjohn Co 3,4,5,10-tetrahydroazepino(2,3-b)indol-5a (2h)-ols
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
SU482086A1 (ru) * 1973-11-30 1976-03-15 Всесоюзный Научно-Исследовательски% Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных 1- -амино1,2,3,4-тетрагидрокарбазола
JPS5111760A (de) * 1974-06-18 1976-01-30 Ayerst Mckenna & Harrison
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles

Also Published As

Publication number Publication date
FI920192A0 (fi) 1992-01-16
FI107919B (fi) 2001-10-31
GR3025318T3 (en) 1998-02-27
NO178397B (no) 1995-12-11
RO112505B1 (ro) 1997-10-30
HUT67027A (en) 1995-01-30
EP0496314A1 (de) 1992-07-29
FI102174B (fi) 1998-10-30
CZ282732B6 (cs) 1997-09-17
JP2665422B2 (ja) 1997-10-22
BR9200171A (pt) 1992-10-06
PH31429A (en) 1998-11-03
NO920235L (no) 1992-07-20
PL169417B1 (pl) 1996-07-31
DE69222444T2 (de) 1998-06-04
IL100693A0 (en) 1992-09-06
NZ241305A (en) 1994-10-26
DE69222444D1 (de) 1997-11-06
CA2059610C (en) 2002-04-02
JPH04334367A (ja) 1992-11-20
AU1027992A (en) 1992-07-23
PL167465B1 (pl) 1995-09-30
DK0496314T3 (da) 1998-05-18
NO920235D0 (no) 1992-01-17
PL296651A1 (en) 1993-07-26
NO178397C (no) 1996-03-20
EP0496314B1 (de) 1997-10-01
KR100230881B1 (ko) 1999-11-15
MX9200206A (es) 1992-08-01
RU2077530C1 (ru) 1997-04-20
FI102174B1 (fi) 1998-10-30
AU650315B2 (en) 1994-06-16
KR920014777A (ko) 1992-08-25
FI20001775A (fi) 2000-08-10
FI920192A (fi) 1992-07-19
ES2109953T3 (es) 1998-02-01
IE920149A1 (en) 1992-07-29
CS12992A3 (en) 1992-08-12
HU9200172D0 (en) 1992-04-28
TW198024B (de) 1993-01-11
PL293209A1 (en) 1993-04-05
US5100891A (en) 1992-03-31
CA2059610A1 (en) 1992-07-19
ATE158790T1 (de) 1997-10-15

Similar Documents

Publication Publication Date Title
ZA92341B (en) Substituted 1,2,3,4-tetrahydrocyclopent(b)indoles,1,2,3,3a,4,8a-hexahydrocyclopent(b)indoles and related compounds,intermediates and a process for the preparation thereof and their use as medicaments
EP0669920A4 (de) Substituierte 3-(aminoalkylamino)-1,2-benzisoxazole und verwandte verbindungen.
IL101819A0 (en) Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants
MY133445A (en) 2-arylethyl-(piperidin-4-ylmethyl)amine derivetives
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
GR3018558T3 (en) [(Arylalkylpiperidine-4-yl)methyl]-2-alpha,3,4,5-tetrahydro-1(2H)-acenaphthylene-1-ones and related compounds, a process for their preparation and their use as medicaments
UA26893C2 (uk) Спосіб отримаhhя оhдасетроhу та його фармацевтичhо прийhятhих солей
DE69533214D1 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
BR9707004A (pt) Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento
DE69709252D1 (de) Coumarin-Derivate, Verfahren zu deren Herstellung und deren Verwendung
UA74426C2 (uk) Фенілпіперазини
DK0758336T3 (da) Fremgangsmåde til fremstilling af 1-(3-trialkylsilylphenyl)-2,2,2-trifluorethanonderivater
IL111404A (en) Pharmaceutical compositions for the enhancement ofmemory and cognition comprising 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles and some such novel compounds
ATE247641T1 (de) Pyridin-zwischenprodukte, verwendbar zur herstellung von beta-adrenergischen rezeptor- agonisten
ZA924888B (en) Process for the synthesis of enantiomers of 3-aminochroman compounds
FI875602A0 (fi) Optiskt aktivt tetrahydro-2-furanonderivat saosom miksobicid.
TW429249B (en) Process for production a novel N-substituted pyrrolidine derivatives